Idexx Laboratories Inc IDXX
$704.23
+0.89%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (5 Buy · 4 Hold · 0 Sell)
- Average Price Target
- $723.57
- Implied Upside
- +2.7%
- Price Target Range
- $670.00 – $810.00
- Analysts (12 mo)
- 9
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-03 | Morgan StanleyErin Wright |
Maintains | Overweight | $805 → $810 |
| 2026-11-03 | UBSAndrea Alfonso |
Maintains | Neutral | $627 → $700 |
| 2026-10-30 | BTIGMark Massaro |
Suspends | Buy | — |
| 2026-10-27 | UBSAndrea Alfonso |
Maintains | Neutral | $670 → $627 |
| 2026-10-16 | JP MorganChris Schott |
Maintains | Overweight | $775 → $750 |
| 2026-10-12 | KeybancSteve Dechert |
Initiates coverage on | Sector weight | — |
| 2026-08-11 | BarclaysGlen Santangelo |
Maintains | Overweight | $800 → $710 |
| 2026-08-05 | UBSAndrea Alfonso |
Maintains | Neutral | $620 → $670 |
| 2026-08-05 | CitigroupDaniel Grosslight |
Maintains | Neutral | $650 → $670 |
| 2026-07-27 | UBSAndrea Alfonso |
Maintains | Neutral | $640 → $620 |
| 2026-04-28 | UBSAndrea Alfonso |
Maintains | Neutral | $730 → $640 |
| 2026-04-15 | CitigroupDaniel Grosslight |
Initiates coverage on | Neutral | $650 |
| 2026-03-31 | StifelJonathan Block |
Maintains | Buy | $775 → $675 |
| 2026-02-09 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $775 → $750 |
| 2026-02-05 | BarclaysGlen Santangelo |
Maintains | Overweight | $850 → $800 |
| 2026-02-03 | UBSAndrea Alfonso |
Maintains | Neutral | $750 → $730 |
| 2026-02-03 | BTIGMark Massaro |
Maintains | Buy | $830 → $800 |
| 2025-12-09 | BarclaysGlen Santangelo |
Initiates coverage on | Overweight | $850 |
| 2025-11-04 | Morgan StanleyErin Wright |
Maintains | Overweight | $765 → $805 |
| 2025-11-04 | UBSAndrea Alfonso |
Maintains | Neutral | $710 → $750 |
| 2025-11-04 | JP MorganChris Schott |
Maintains | Overweight | $675 → $775 |
| 2025-11-04 | BTIGMark Massaro |
Maintains | Buy | $785 → $830 |
| 2025-10-31 | StifelJonathan Block |
Upgrades | Hold → Buy | $640 → $700 |
| 2025-10-01 | UBSAndrea Alfonso |
Initiates coverage on | Neutral | $720 |
| 2025-08-15 | Morgan StanleyErin Wright |
Maintains | Overweight | $722 → $765 |
| 2025-08-11 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $510 → $700 |
| 2025-08-04 | JP MorganChris Schott |
Maintains | Overweight | $550 → $675 |
| 2025-07-17 | Leerink PartnersDaniel Clark |
Maintains | Outperform | $580 → $600 |
| 2025-07-02 | StifelJonathan Block |
Maintains | Hold | $510 → $540 |
| 2025-06-11 | Leerink PartnersDaniel Clark |
Maintains | Outperform | $515 → $580 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $704.23
- Market Cap
- $55.48 billion
- 52-Week Range
- $500.61 – $769.98
- Average Volume
- 658K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
